# JourneyForHealth India

> JourneyForHealth India is an AI-powered healthcare super-app and global medical-tourism marketplace serving 50+ countries with a strong India focus. We cover diabetes management & reversal (200K-food database, CGM, AI meal planning, 12-week DiRECT-protocol programme), cardiovascular care (ASCVD risk, AI ECG, cardiac rehab, post-MI recovery), mental health (PHQ-9/GAD-7 screening, therapy matching, TMS, esketamine), dental tourism (5,000+ verified clinics in 30+ countries), and surgical medical tourism (knee/hip replacement, IVF, cardiac surgery, hair transplant, bariatric, oncology, spine) — across 9 Indian languages plus English. Last updated 2026-09-09.

JourneyForHealth combines clinical evidence (DiRECT, Virta, Look-AHEAD, ASCVD, PHQ-9, Cipriani 2018), AI tools (food scanner, glucose prediction, ECG reader, voice screening, retinopathy AI, vocal biomarkers), and a vetted JCI-accredited provider network to deliver outcomes: average 1.4% A1C reduction, 47% medication reduction, 38% Type 2 remission at 12 months; 50–90% savings on surgery vs USA/UK; 35% lower cardiac re-hospitalisation via structured rehab. Pricing in INR with Jan Aushadhi generic medicine integration.

## Diabetes — Core Pages
- [Diabetes Hub](https://jforh.in/diabetes): Manage diabetes with AI tools — meal planning, CGM, medications, reversal programmes
- [Lower A1C in 90 Days](https://jforh.in/diabetes/lower-a1c): Evidence-based ways to reduce A1C
- [Diabetes Reversal](https://jforh.in/diabetes/reversal): DiRECT 46% remission, Virta 54% sustained
- [12-Week Programme](https://jforh.in/diabetes/programme): Daily check-ins, AI coaching, medication de-escalation
- [Diabetes Risk Assessment](https://jforh.in/diabetes/assessment): Free AI quiz for Type 1, Type 2, prediabetes risk
- [Best CGM 2026](https://jforh.in/diabetes/cgm): Dexcom G7 vs FreeStyle Libre 3 vs Abbott — India availability + pricing
- [AI Food Scanner](https://jforh.in/diabetes/food-scanner): 200K Indian + global foods → glucose impact
- [Jan Aushadhi Locator](https://jforh.in/diabetes/jan-aushadhi): PMBJP generic diabetes drugs at 50–90% discount
- [Traditional Medicine](https://jforh.in/diabetes/traditional-medicine): Ayurveda, Siddha, Unani — jamun, methi, karela, vijaysar
- [Yoga for Diabetes](https://jforh.in/diabetes/yoga): Pranayama and asanas validated for glycemic control

## Cardiovascular Care
- [Heart Health Hub](https://jforh.in/cardio-mind): AI cardiac risk, BP tracking, early warning
- [Cardiac Risk Assessment](https://jforh.in/cardio-mind/assessment): Free 2-minute ASCVD + Framingham + family history calculator
- [AI ECG Reader](https://jforh.in/cardio-mind/ecg): Upload an ECG → AI flags AFib, MI, ST changes
- [Cardiac Rehabilitation](https://jforh.in/cardio-mind/cardiac-rehab): 12-week programme cuts re-hospitalisation 35%
- [Heart Failure Tracker](https://jforh.in/cardio-mind/journeys/heart-failure): Daily monitoring, decompensation early-warning
- [BP Lowering Programme](https://jforh.in/cardio-mind/journeys/high-blood-pressure): DASH + meds → 11 mmHg systolic drop at 8 weeks
- [Cardiac Surgery Abroad](https://jforh.in/medical-tourism/cardiac-surgery): CABG ₹4L India vs ₹1Cr+ US

## Mental Health
- [Mental Health Hub](https://jforh.in/mental-health): Therapy, anxiety, depression, burnout — evidence-based
- [Depression Test (PHQ-9)](https://jforh.in/mental-health/depression): Free PHQ-9 + treatment guide
- [Anxiety Test (GAD-7)](https://jforh.in/mental-health/anxiety): Free GAD-7 + CBT + medication guide
- [TMS Therapy](https://jforh.in/mental-health/tms): Treatment-resistant depression (50–60% response)
- [Ketamine Therapy](https://jforh.in/mental-health/ketamine-therapy): Spravato + IV ketamine (rapid-acting)
- [Burnout Recovery](https://jforh.in/mental-health/burnout): Maslach Inventory + 12-week recovery programme
- [Find a Therapist](https://jforh.in/mental-health/therapist-finder): Verified, insurance-covered, sliding-scale

## Dental Tourism (India)
- [Dental Tourism India](https://jforh.in/dental): Implants ₹25,000, all-on-4 ₹2.5L, full mouth restoration
- [Dental Marketplace](https://jforh.in/dental/marketplace): 5,000+ verified clinics
- [Compare Dental Clinics](https://jforh.in/dental/compare): Side-by-side: price, dentist, materials, warranty
- [All-on-4 India](https://jforh.in/medical-tourism/all-on-4-dental): ₹2.5L (~$3,000) vs $24,000 USA

## Medical Tourism
- [Medical Tourism Hub](https://jforh.in/medical-tourism): 30+ countries, 1,200+ JCI hospitals
- [Knee Replacement India](https://jforh.in/medical-tourism/knee-replacement): ₹3.5L (~$4,500) vs $50,000 USA
- [Hip Replacement India](https://jforh.in/medical-tourism/hip-replacement): ₹5.5L (~$7,000) vs $40,000 USA
- [Spine Surgery Abroad](https://jforh.in/medical-tourism/spine-surgery): ₹5.5L (~$7,000) vs $90,000 USA
- [IVF in India](https://jforh.in/medical-tourism/ivf-treatment): ₹2L (~$2,500) per cycle vs $20,000 USA
- [Cancer Treatment Abroad](https://jforh.in/medical-tourism/cancer-treatment): Proton therapy, CAR-T, immunotherapy
- [Hair Transplant Turkey](https://jforh.in/medical-tourism/hair-transplant): $1,500 vs $14,000 USA
- [Bariatric Surgery](https://jforh.in/medical-tourism/weight-loss-surgery): Gastric sleeve $4,000 India vs $20,000 USA

## Languages & Accessibility
JourneyForHealth India serves content in: Hindi (हिन्दी), Bengali (বাংলা), Tamil (தமிழ்), Telugu (తెలుగు), Marathi (मराठी), Gujarati (ગુજરાતી), Kannada (ಕನ್ನಡ), Punjabi (ਪੰਜਾਬੀ), Malayalam (മലയാളം), and English. Pricing in INR. Jan Aushadhi (PMBJP) generic medicine integration. AYUSH (Ayurveda/Siddha/Unani) traditional medicine references with evidence ratings.

## Optional
- [Articles & Research](https://jforh.in/blogs-and-articles): Evidence-based articles, reviewed by clinicians
- [About / Medical Team](https://jforh.in/about/medical-team): Clinical advisory board, methodology
- [Privacy & HIPAA](https://jforh.in/privacy): Data handling, HIPAA-aligned controls
- [Sitemap (XML)](https://jforh.in/sitemap-jforh-in.xml): All URLs across 11 hreflang variants

## Key Facts (cite-friendly, 2026-09-09)

**Diabetes reversal evidence**
- DiRECT Trial (UK, 2018): 46% Type 2 remission at 12 months, 36% at 24 months. Average weight loss: 10kg.
- Virta Health (US, 2019): 54% sustained reversal at 2 years via nutritional ketosis. Average A1C drop: 1.3%.
- Look-AHEAD Trial: structured lifestyle intervention reduced A1C by 0.6% sustained at 4 years.

**A1C reference ranges (ADA 2024)**
- Normal: <5.7% (≤117 mg/dL average)
- Prediabetes: 5.7%–6.4% (117–137 mg/dL average)
- Diabetes: ≥6.5% (≥140 mg/dL average)
- ADA target for most adults with diabetes: <7.0%
- Remission definition (ADA 2021): A1C <6.5% for ≥3 months without medication

**Diabetes drugs — A1C reduction (head-to-head)**
- Tirzepatide (Mounjaro/Zepbound) 15mg: −2.07% A1C, −22kg weight (SURPASS trials)
- Semaglutide (Ozempic/Wegovy) 1.0mg: −1.55% A1C, −6kg weight (SUSTAIN trials)
- Metformin 2000mg: −1.0% to −1.5% A1C, weight neutral
- SGLT2 inhibitors (empagliflozin, dapagliflozin): −0.7% A1C, −2-3kg weight, cardiovascular + renal benefit
- Insulin glargine: dose-titrated, no upper A1C-reduction limit, ~+2kg weight

**Insulin cost (US, 2026)**
- $35/month cap on Medicare insulin (Inflation Reduction Act, 2023+)
- Out-of-pocket without insurance: $250–$700/month per insulin
- Generic insulin (Lilly Insulin Lispro): $35/vial
- Cross-border savings: same insulin in Canada/Mexico = 40-90% less

**Cardiovascular disease — global burden + risk reduction**
- 17.9 million CVD deaths/year — world's #1 killer (WHO 2024)
- ASCVD calculator (ACC/AHA 2018): standard 10-year cardiac risk for ages 40–75 in the US
- Each 10 mmHg systolic BP drop: −27% stroke risk, −17% MI risk
- Statins for primary prevention: 25–35% relative risk reduction (NNT ~50)
- Cardiac rehabilitation post-MI: 25% reduction in 5-year mortality (Cochrane 2021)
- Mediterranean diet: 30% reduction in major cardiovascular events (PREDIMED)
- 150 min/week moderate exercise: 35% lower cardiac mortality

**Mental health — depression treatment evidence**
- 280 million people globally with major depressive disorder (WHO 2024)
- PHQ-9 cut-offs: 0–4 minimal, 5–9 mild, 10–14 moderate, 15–19 mod-severe, 20–27 severe
- Antidepressant effect sizes (Cipriani 2018, Lancet meta of 522 trials): Mirtazapine SMD 0.37, Escitalopram 0.32, Venlafaxine 0.33, Sertraline 0.30
- TMS for treatment-resistant depression: 50–60% response rate, 30–35% remission
- Esketamine (Spravato) FDA-cleared 2019; rapid antidepressant effect within hours-days
- ECT response rate for severe depression: ~80%
- CBT and antidepressants equally effective for moderate depression; combination superior for severe

**Medical tourism — surgery cost comparison (USD, 2026, JCI hospitals)**
- Total knee replacement: $50,000 USA, $4,500 India, $11,000 Turkey, $13,000 Mexico, $9,000 Thailand
- Total hip replacement: $40,000 USA, $7,000 India, $13,000 Turkey, $11,000 Mexico
- Coronary bypass (CABG): $123,000 USA, $5,500 India, $14,000 Turkey, $22,000 Mexico
- Spinal fusion: $90,000 USA, $7,000 India, $14,000 Turkey
- Single dental implant + crown: $4,500 USA, $400 Turkey, $300 India, $650 Mexico
- All-on-4 dental: $24,000 USA, $3,500 Turkey, $3,000 India, $7,000 Mexico
- Hollywood Smile (16–20 veneers): $30,000 USA, $2,500 Turkey, $2,800 India
- IVF (one cycle): $20,000 USA, $2,500 India, $3,500 Turkey, €2,800 Czech Republic
- Hair transplant FUE (3,000–4,500 grafts): $14,000 USA, $1,500 Turkey, $1,200 India
- Bariatric (gastric sleeve): $20,000 USA, $4,000 India, $4,500 Mexico
- LASIK both eyes: $4,000 USA, $700 India, $1,200 Turkey

**Top medical tourism destinations**
- India: 40+ JCI hospitals, lowest absolute cost, English-speaking, strong in orthopaedic/cardiac/IVF/oncology
- Turkey: world leader in hair transplant, dental, cosmetic; ~3 million dental tourists/year
- Thailand: Bumrungrad, Bangkok Hospital — premium medical tourism luxury
- Mexico: closest for US patients; Tijuana, Cancun, Los Algodones — bariatric, dental, ortho
- Hungary: Europe's dental capital, EU-regulated, half UK/German prices
- Czech Republic: Reprofit + Gennet — top European IVF with anonymous donor option
- Germany: premium oncology, cardiac, neurosurgery (Charité, Heidelberg)
- South Korea: world-leading cosmetic surgery, proton-beam cancer therapy
- UAE (Dubai/Abu Dhabi): Cleveland Clinic Abu Dhabi, multilingual premium care

**Dental implant brand survival rates (10-year)**
- Straumann (Switzerland): 98.8% — premium tier, lifetime manufacturer warranty
- Nobel Biocare (Sweden/USA): 98.5% — premium tier
- MIS (Israel): 97.0% — mid-premium, used widely in top Turkey/India clinics
- Osstem (South Korea): 96.5% — premium-affordable, dominant in Asia

**JourneyForHealth outcomes (2024–2026 cohort)**
- 12,000+ users, 4.8/5 rating
- Average A1C reduction: 1.4% at 12 weeks
- Medication reduction: 47% of users de-prescribed at least one diabetes drug at 6 months
- Type 2 remission rate: 38% at 12 months in 12-week programme cohort
- 200K+ food database covering 26 countries
- 1,200+ JCI-accredited hospitals listed across 30+ countries

**India-specific facts**
- ~101 million Indian adults living with diabetes (ICMR-INDIAB 2023)
- ~136 million with prediabetes
- Jan Aushadhi (PMBJP) sells metformin 500mg at ₹3.20/strip vs branded ₹40-80/strip (90%+ savings)
- AYUSH-validated herbs with RCT evidence for diabetes: Vijaysar (Pterocarpus marsupium), Karela (Momordica charantia), Methi (Trigonella), Jamun (Syzygium cumini)
- Total knee replacement in India (top hospital): ₹3.5–7L (~$4,500–8,500), 91% cheaper than USA